Literature DB >> 19562268

Computation of brain metabolite ratios in single-voxel proton MR spectroscopy: comparison between semiautomatic and automatic software.

L N Mazzoni1, G Belli, A Ginestroni, A Pratesi, S Agnoloni, S Diciotti, M Mascalchi.   

Abstract

PURPOSE: Metabolite ratios are the measurements most commonly utilised for clinical applications of brain proton magnetic resonance spectroscopy ((1)H-MRS) [1]. We evaluated the agreement between the metabolite ratios calculated with semiautomatic and automatic software.
MATERIALS AND METHODS: Two single-voxel spectra (3.375 ml) localised in the frontal grey matter (GM) and peritrigonal white matter (WM) were obtained in 20 healthy subjects by using a point-resolved proton spectroscopy sequence (PRESS, TE=144 ms). The spectra were processed using the semiautomatic software J-Magnetic Resonance User Interface (JMRUI) and the automatic software SpectroView. Agreement of the N-acetyl-aspartate (NAA)/creatine (Cr), NAA/choline (Cho) and Cho/Cr ratios calculated with the two methods was assessed by estimating the 95% limits of agreement (LAs) of the differences of the values obtained with the two software packages.
RESULTS: Mean values and standard deviations of NAA/Cr, Cho/Cr and NAA/Cho (semiautomatic//automatic software) were 1.99+/-0.53//1.73+/-0.36, 1.13+/-0.40//1.04+/-0.33, 1.85+/-0.62//1.89+/-0.69 for the GM and 2.24+/-0.41//2.37+/-0.27, 0.96+/-0.17//1.13+/-0.15, 2.37+/-0.43//2.11+/-0.23 for the WM. The 95% LAs were wider for GM spectra and ranged between -0.51, 0.17 for Cho/Cr in the WM and -1.54, 1.47 for NAA/Cho in the GM.
CONCLUSIONS: The difference between brain metabolite ratios calculated with the two software packages is not negligible and reflects spectral quality.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19562268     DOI: 10.1007/s11547-009-0408-4

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   3.469


  15 in total

1.  Quantifying in vivo MR spectra with circles.

Authors:  Refaat E Gabr; Ronald Ouwerkerk; Paul A Bottomley
Journal:  J Magn Reson       Date:  2005-12-01       Impact factor: 2.229

2.  Quantification of MRS data in the frequency domain using a wavelet filter, an approximated Voigt lineshape model and prior knowledge.

Authors:  P Gillies; I Marshall; M Asplund; P Winkler; J Higinbotham
Journal:  NMR Biomed       Date:  2006-08       Impact factor: 4.044

3.  Improved method for accurate and efficient quantification of MRS data with use of prior knowledge

Authors: 
Journal:  J Magn Reson       Date:  1997-11       Impact factor: 2.229

4.  Human cardiac high-energy phosphate metabolite concentrations by 1D-resolved NMR spectroscopy.

Authors:  P A Bottomley; E Atalar; R G Weiss
Journal:  Magn Reson Med       Date:  1996-05       Impact factor: 4.668

5.  Single-voxel long TE 1H-MR spectroscopy of the normal brainstem and cerebellum.

Authors:  Mario Mascalchi; Roberto Brugnoli; Laura Guerrini; Giacomo Belli; Marco Nistri; Letterio S Politi; Cinzia Gavazzi; Francesco Lolli; Giovanni Argenti; Natale Villari
Journal:  J Magn Reson Imaging       Date:  2002-11       Impact factor: 4.813

6.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

7.  Subcortical damage and cortical functional changes in men and women with Fabry disease: a multifaceted MR study.

Authors:  Cinzia Gavazzi; Walter Borsini; Laura Guerrini; Riccardo Della Nave; Maria Assunta Rocca; Carlo Tessa; Suzanne Buchner; Giacomo Belli; Massimo Filippi; Natale Villari; Mario Mascalchi
Journal:  Radiology       Date:  2006-11       Impact factor: 11.105

8.  Association between cortical metabolite levels and clinical manifestations of migrainous aura: an MR-spectroscopy study.

Authors:  U G Schulz; A M Blamire; R G Corkill; P Davies; P Styles; P M Rothwell
Journal:  Brain       Date:  2007-10-22       Impact factor: 13.501

9.  Myocardial high-energy phosphate metabolism and allograft rejection in patients with heart transplants.

Authors:  P A Bottomley; R G Weiss; C J Hardy; W A Baumgartner
Journal:  Radiology       Date:  1991-10       Impact factor: 11.105

10.  Lafora disease: spectroscopy study correlated with neuropsychological findings.

Authors:  Anna Pichiecchio; Pierangelo Veggiotti; Simonetta Cardinali; Francesca Longaretti; Guy U Poloni; Carla Uggetti
Journal:  Eur J Paediatr Neurol       Date:  2007-12-11       Impact factor: 3.140

View more
  3 in total

1.  Reproducibility of brain metabolite concentration measurements in lesion free white matter at 1.5 T.

Authors:  Martin H J Busch; Wolfgang Vollmann; Serban Mateiescu; Manuel Stolze; Martin Deli; Marietta Garmer; Dietrich H W Grönemeyer
Journal:  BMC Med Imaging       Date:  2015-09-29       Impact factor: 1.930

2.  Insight into Metabolic 1H-MRS Changes in Natalizumab Induced Progressive Multifocal Leukoencephalopathy Brain Lesions.

Authors:  Ruth Schneider; Barbara Bellenberg; Robert Hoepner; Gisa Ellrichmann; Ralf Gold; Carsten Lukas
Journal:  Front Neurol       Date:  2017-09-05       Impact factor: 4.003

3.  Metabolic profiles by 1H-magnetic resonance spectroscopy in natalizumab-associated post-PML lesions of multiple sclerosis patients who survived progressive multifocal leukoencephalopathy (PML).

Authors:  Ruth Schneider; Barbara Bellenberg; Robert Hoepner; Eva-Maria Kolb; Gisa Ellrichmann; Aiden Haghikia; Ralf Gold; Carsten Lukas
Journal:  PLoS One       Date:  2017-04-26       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.